Microbot Medical targets $4M in 2026 revenue with the LIBERTY robotic system launch and a $1.9 price target after its capital raise. See why MBOT stock is a hold.

Limited Market Release (LMR) of the LIBERTY® System is on Schedule Building on Positive Customer Feedback and Growing Market ...

Microbot Medical Inc. announces a direct offering of common stock and a concurrent private placement, raising approximately $13 million. Microbot Medical Inc. announced a registered direct offering ...

HINGHAM, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), announced that Harel Gadot, Chairman, President and CEO, will be presenting at the H.C. Wainwright 24th Annual Global ...

HINGHAM, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical ...

Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Microbot Medical Inc. has appointed Ms. Michal Ahuvia as the new Director of Operations to enhance production and efficiency ahead of the commercial launch of their LIBERTY® Endovascular Robotic ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

BRAINTREE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Robotic Surgical System, today announces additional updates regarding ...

The MarketWatch News Department was not involved in the creation of this content. HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of ...

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under ...

Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...